血清脂质相关指标与乳腺癌关系的研究进展  

Research Progress on the Relationship Between Serum Lipid-related Indexes and Breast Cancer

作　　者：赵静[1] 邱刚[1] 钱祎萌 张立涛[2] 张爽 ZHAO Jing;QIU Gang;QIAN Yimeng;ZHANG Litao;ZHANG Shuang(Department of Oncology,Hebei General Hospital,Shijiazhuang 050051,China;Department of Emergency,Hebei General Hospital,Shijiazhuang 050051,China;School of Graduate Studies,Hebei North University,Zhangjiakou,Hebei 075000,China)

机构地区：[1]河北省人民医院肿瘤科,石家庄050051 [2]河北省人民医院急诊科,石家庄050051 [3]河北北方学院研究生院,河北张家口075000

出　　处：《临床误诊误治》2024年第7期97-100,共4页Clinical Misdiagnosis & Mistherapy

基　　金：河北省省级科技计划项目(20377749D);政府资助临床医学优秀人才培养项目(202224)。

摘　　要：脂代谢紊乱与乳腺癌的发生发展及预后密切相关。探索血清脂质相关指标、降脂药物对乳腺癌发病及预后的影响,有助于寻找乳腺癌新的生化标志物,发现新的治疗靶点并对其进行更精准的个体化治疗。本文通过查阅相关文献,就血清脂质相关指标与乳腺癌之间的关系做一综述,为深入研究乳腺癌的发病机制及乳腺癌的预防、诊断及治疗提供新的方向。Lipid metabolism disorder is closely related to the occurrence,development and prognosis of breast cancer.Exploring the impact of plasma lipid-related indexes and lipid-lowering drugs on the incidence and prognosis of breast cancer is helpful to find new biochemical markers of breast cancer,discover new therapeutic targets and conduct more accurate individualized treatment.This article reviews the relationship between serum lipid-related indexes and breast cancer by consulting relevant literature,which provides a new direction for in-depth study of the pathogenesis of breast cancer and the prevention,diagnosis and treatment of breast cancer.

关 键 词：乳腺肿瘤 血脂 脂质 胆固醇 三酰甘油 他汀类药物 治疗 综述 

分 类 号：R737.9[医药卫生—肿瘤]